Treatment of Meibomian Gland Dysfunction and Ocular Rosacea

Introduction to Doxycycline Treatment

Doxycycline is prescribed at 100mg for Meibomian Gland Dysfunction (MGD) and at 40-50mg for ocular rosacea, as the lower anti-inflammatory dose is sufficient for ocular rosacea while avoiding antibiotic resistance, whereas MGD often requires higher doses for effective treatment of the more severe gland obstruction 1

Doxycycline has anti-inflammatory effects, including decreasing lipase production in both S. epidermidis and S. aureus, inhibiting matrix metalloproteinases affecting the cathelicidin cascade, and affecting neutrophil chemotaxis 1, 2
Doxycycline has antimicrobial effects only present at doses ≥50mg 2

The American Academy of Ophthalmology recommends doxycycline for MGD when symptoms and signs are not adequately controlled by eyelid cleansing or meibomian gland expression 1, 3
The recommended treatment sequence is:

Clinical studies show 100mg doxycycline is effective for MGD with improvements in Meibomian gland function and tear film stability 1
The 40mg modified-release doxycycline has fewer gastrointestinal side effects compared to doses ≥50mg and reduces the risk of antibiotic resistance 2, 5
Doxycycline improves tear break-up time in patients with MGD 1
Doxycycline improves meibomian gland function by reducing inflammation 3

Contraindications for all doses include pregnancy, nursing women, children under 8 years, and history of hypersensitivity to tetracyclines 1, 3
Higher doses increase the risk of photosensitization, gastrointestinal upset, vaginitis, and potential drug interactions with oral contraceptives and warfarin 1, 3
Doxycycline may cause side effects such as photosensitization, gastrointestinal upset, vaginitis, and rarely azotemia 3, 1
Doxycycline may decrease the effectiveness of oral contraceptives and potentiate the effect of warfarin 3, 1

Both conditions typically require 2-3 months of treatment, with treatment may need to be intermittently discontinued and reinstated based on severity and medication tolerance 1, 3
For patients who cannot take doxycycline, oral erythromycin or azithromycin can be used, especially in women of childbearing age and children, and sustained-release preparations can help reduce side effects 1, 3
Long-term management is often necessary as symptoms typically recur when treatment is discontinued 4
Doxycycline can be tapered after clinical improvement is noted 3, 1